Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

An important information source for pharmacotherapy in populations at risk is drug labelling. We compared the recommendations for patients with renal insufficiency included in German drug labellings with evidence from the literature.

Saved in:

Bibliographic Details
Main Authors:	Martin-Facklam, Meret (Author) , Rengelshausen, Jens (Author) , Tayrouz Haffar, Yorki Antoine (Author) , Ketabi-Kiyanvash, Nahal (Author) , Lindenmaier, Heike (Author) , Schneider, Verena Janina (Author) , Bergk, Verena (Author) , Haefeli, Walter E. (Author)
Format:	Article (Journal)
Language:	English
Published:	2005
In:	European journal of clinical pharmacology Year: 2005, Volume: 60, Issue: 11, Pages: 807-811
ISSN:	1432-1041
DOI:	10.1007/s00228-004-0852-y
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-004-0852-y
Author Notes:	Meret Martin-Facklam, Jens Rengelshausen, Yorki Tayrouz, Nahal Ketabi-Kiyanvash, Heike Lindenmaier, Verena Schneider, Verena Bergk, Walter E. Haefeli

Description
Summary:	An important information source for pharmacotherapy in populations at risk is drug labelling. We compared the recommendations for patients with renal insufficiency included in German drug labellings with evidence from the literature.
Item Description:	Published: 14 December 2004 Gesehen am 18.05.2021
Physical Description:	Online Resource
ISSN:	1432-1041
DOI:	10.1007/s00228-004-0852-y